NTUS
$20.97
Natus Medical
$.55
2.69%
NTUS
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $0.24
Revenue:  $105.40 Mil
Thursday
Jan 28
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when NTUS reports earnings?
Beat
Meet
Miss

Where is NTUS's stock price going from here?
Up
Flat
Down
Stock chart of NTUS
Analysts
Summary of analysts' recommendations for NTUS
Score
Grade
Pivots
Resistance
$21.24
$20.86
$20.64

$20.26

Support
$20.04
$19.66
$19.44
Tweet
Growth
Description
Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.